At a later stage of tumor development, when CD4+ Treg cells dominate the tumor-microenvironment, CD4+ Tregs mediate the clonal deletion of these tumor-suppressive KIR+ IFNγ+ CD25+ CD8+ T cells and ensure tumor immune evasion. This evidence concerns the gene CD8A and neoplasm.